Bis[(para-methoxy)benzyl] phosphonate prodrugs with improved stability and enhanced cell penetration
- 15 June 2007
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (12), 3412-3416
- https://doi.org/10.1016/j.bmcl.2007.03.089
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetesProceedings of the National Academy of Sciences of the United States of America, 2005
- Liver-Targeted Drug Delivery Using HepDirect ProdrugsJournal of Pharmacology and Experimental Therapeutics, 2004
- Design, Synthesis, and Characterization of a Series of Cytochrome P450 3A-Activated Prodrugs (HepDirect Prodrugs) Useful for Targeting Phosph(on)ate-Based Drugs to the Liver§Journal of the American Chemical Society, 2004
- Synthesis of phosphonate 3-phthalidyl esters as prodrugs for potential intracellular delivery of phosphonatesBioorganic & Medicinal Chemistry Letters, 1999
- Prodrugs of phosphates, phosphonates, and phosphinatesAdvanced Drug Delivery Reviews, 1996
- Mononucleoside Phosphotriester Derivatives with S-Acyl-2-thioethyl Bioreversible Phosphate-Protecting Groups: Intracellular Delivery of 3'-Azido-2',3'-dideoxythymidine 5'-MonophosphateJournal of Medicinal Chemistry, 1995
- N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) InhibitorsJournal of Medicinal Chemistry, 1994
- Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZTAntiviral Research, 1992
- Biologically Reversible Phosphate-Protective GroupsJournal of Pharmaceutical Sciences, 1983
- Measurement of Transmembrane Potentials in Phospholipid VesiclesProceedings of the National Academy of Sciences of the United States of America, 1972